133 related articles for article (PubMed ID: 3009062)
1. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
Armitage RJ; Cawley JC
Clin Exp Immunol; 1986 Feb; 63(2):298-302. PubMed ID: 3009062
[TBL] [Abstract][Full Text] [Related]
2. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
3. Activated human B cells display a functional IL 2 receptor.
Mittler R; Rao P; Olini G; Westberg E; Newman W; Hoffmann M; Goldstein G
J Immunol; 1985 Apr; 134(4):2393-9. PubMed ID: 2982945
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
5. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
Saiki O; Tanaka T; Doi S; Kishimoto S
J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
[TBL] [Abstract][Full Text] [Related]
6. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
7. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
8. Functional interleukin 2 receptors on B cells lacking Tac antigens.
Tanaka T; Saiki O; Doi S; Hatakeyama M; Doi T; Kono T; Mori H; Fujii M; Sugamura K; Negoro S
Eur J Immunol; 1987 Sep; 17(9):1379-82. PubMed ID: 2820752
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Bouguet J; Fradelizi D; Reyes F
J Immunol; 1985 Sep; 135(3):1813-8. PubMed ID: 3926884
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
Gordon J; Webb AJ; Walker L; Guy GR; Rowe M
Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819
[TBL] [Abstract][Full Text] [Related]
12. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
13. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
14. Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation.
Tanaka T; Saiki O; Doi S; Suemura M; Negoro S; Kishimoto S
J Clin Invest; 1988 Jul; 82(1):316-21. PubMed ID: 2839549
[TBL] [Abstract][Full Text] [Related]
15. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
Bich-Thuy LT; Dukovich M; Peffer NJ; Fauci AS; Kehrl JH; Greene WC
J Immunol; 1987 Sep; 139(5):1550-6. PubMed ID: 3040856
[TBL] [Abstract][Full Text] [Related]
16. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.
Lotze MT; Custer MC; Sharrow SO; Rubin LA; Nelson DL; Rosenberg SA
Cancer Res; 1987 Apr; 47(8):2188-95. PubMed ID: 3030546
[TBL] [Abstract][Full Text] [Related]
17. Expression of functional interleukin 2 receptors on chronic lymphocytic leukaemia B lymphocytes is modulated by recombinant interleukin 2.
Murphy JJ; Malkovska V; Hudson L; Millard RE
Clin Exp Immunol; 1987 Oct; 70(1):182-91. PubMed ID: 3121222
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
Lillehoj HS; Malek TR; Shevach EM
J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
Taniguchi N; Miyawaki T; Yachie A
Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
[No Abstract] [Full Text] [Related]
20. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
